Thimerosal Exposure in Infants and Developmental Disorders: A
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Adverse Effects of Vaccines: Evidence and Causality
REPORT BRIEF AUGUST 2011 .For more information visit www.iom.edu/vaccineadverseeffects Adverse Effects of Vaccines Evidence and Causality Immunizations are a cornerstone of the nation’s efforts to protect people from a host of infectious diseases. As required by the Food and Drug Admin- istration, vaccines are tested for safety before they enter the market, and their performance is continually evaluated to identify any risks that might appear over time. Vaccines are not free from side effects, or “adverse effects,” but most are very rare or very mild. Importantly, some adverse health problems following a vaccine may be due to coincidence and are not caused by the vaccine. As part of the evaluation of vaccines over time, researchers assess evidence to deter- As part of the evaluation of mine if adverse events following vaccination are causally linked to a specific vaccines over time, researchers vaccine, and if so, they are referred to as adverse effects. Under the National assess evidence to determine if Childhood Vaccine Injury Act of 1986, Congress established the National Vac- adverse events following cine Injury Compensation Program (VICP) to provide compensation to peo- vaccination are causally linked to ple injured by vaccines. Anyone who thinks they or a family member—often a a specific vaccine, and if so, they are referred to as adverse effects. child—has been injured can file a claim. The Health Resources and Services Administration (HRSA), the agency within the Department of Health and Human Services that administers VICP, can use evidence that demonstrates a causal link between an adverse event and a vaccine to streamline the claim process. -
Autism 2002 Mercury, Heavy Metals
Autism 2002 Mercury, Heavy Metals... Toxicity Stephanie Cave, M.D., F.A.A.F.P. Dr. Cave received her M.D. from LSU Medical School in New Orleans, Louisiana in 1983. She completed a residency in 1986 and is board certified in Family Practice. She and her colleague, Dr. Amy Holmes, are presently treating over 1000 children with Autism Spectrum Disorder in a private clinic in Baton Rouge, Louisiana. Dr. Cave lectures on Autism and Vaccines and has recently published a book titled What Your Doctor May Not Tell You About Children's Vaccinations. Last summer she testified before the United States Congressional Committee on Governmental Reform regarding the mercury content in vaccines. AUTISM AND IMMUNIZATIONS Stephanie F. Cave, M.S., M.D., F.A.A.F.P. I am honored that you have asked me to speak at the Autism 2002 conference. I would like to talk to you about a subject close to my heart---autism spectrum disorder and the possible link to vaccines. Presently my colleague and I are treating over 1500 children with this problem. In the past five years we have seen an incredible number of children recover from this devastating illness and take their places beside their schoolmates and siblings. This subject, as you might expect, is a very controversial one, but I think you will agree with me before the end of this lecture that this is an epidemic in medicine unlike anything that we have seen in the past. The debate about vaccinations has been going on since the smallpox vaccine was given during the early part of the twentieth century. -
Hearing Before the Committee on Government Reform
DOCUMENT RESUME ED 466 915 EC 309 063 TITLE Autism: Present Challenges, Future Needs--Why the Increased Rates? Hearing before the Committee on Government Reform. House of Representatives, One Hundred Sixth Congress, Second Session (April 6,2000). INSTITUTION Congress of the U.S., Washington, DC. House Committee on Government Reform. REPORT NO House-Hrg-106-180 PUB DATE 2001-00-00 NOTE 483p. AVAILABLE FROM Government Printing Office, Superintendent of Documents, Congressional Sales Office, Washington, DC 20402-9328. Tel: 202-512-1800. For full text: http://www.house.gov/reform. PUB TYPE Legal/Legislative/Regulatory Materials (090) EDRS PRICE EDRS Price MF02/PC20 Plus Postage. DESCRIPTORS *Autism; *Child Health; Children; *Disease Control; *Etiology; Family Problems; Hearings; *Immunization Programs; Incidence; Influences; Parent Attitudes; *Preventive Medicine; Research Needs; Symptoms (Individual Disorders) IDENTIFIERS Congress 106th; Vaccination ABSTRACT This document contains the proceedings of a hearing on April 6, 2000, before the U.S. House of Representatives Committee on Government Reform. The hearing addressed the increasing rate of children diagnosed with autism, possible links between autism and childhood vaccinations, and future needs of these children. After opening statements by congressmen on the Committee, the statements and testimony of Kenneth Curtis, James Smythe, Shelley Reynolds, Jeana Smith, Scott Bono, and Dr. Wayne M. Danker, all parents of children with autism, are included. Their statements discuss symptoms of autism, vaccination concerns, family problems, financial concerns, and how parents can be helped. The statements and testimony of the second panel are then provided, including that of Andrew Wakefield, John O'Leary, Vijendra K. Singh, Coleen A. Boyle, Ben Schwartz, Paul A. -
Addressing the Justifications for Vaccine Denial and Applying The
University of Northern Iowa UNI ScholarWorks Honors Program Theses Honors Program 2016 A healthy herd: addressing the justifications for accinev denial and applying the health belief model to the current anti- vaccination movement Sarah L. McHugh University of Northern Iowa Let us know how access to this document benefits ouy Copyright ©2016 Sarah L. McHugh Follow this and additional works at: https://scholarworks.uni.edu/hpt Part of the Infectious Disease Commons, and the Preventive Medicine Commons Recommended Citation McHugh, Sarah L., "A healthy herd: addressing the justifications for accinev denial and applying the health belief model to the current anti-vaccination movement" (2016). Honors Program Theses. 225. https://scholarworks.uni.edu/hpt/225 This Open Access Honors Program Thesis is brought to you for free and open access by the Honors Program at UNI ScholarWorks. It has been accepted for inclusion in Honors Program Theses by an authorized administrator of UNI ScholarWorks. For more information, please contact [email protected]. A HEALTHY HERD: ADDRESSING THE JUSTIFICATIONS FOR VACCINE DENIAL AND APPLYING THE HEALTH BELIEF MODEL TO THE CURRENT ANTI- VACCINATION MOVEMENT A Thesis Submitted in Partial Fulfillment of the Requirements for the Designation University Honors with Distinction Sarah L. McHugh University of Northern Iowa May 2016 This Study by: Sarah L. McHugh Entitled: A Healthy Herd: Addressing the Justifications for Vaccine Denial and Applying the Health Belief Model to the Current Anti-vaccination Movement has been approved as meeting the thesis or project requirement for the Designation University Honors with Distinction __________ ______________________________________________________ Date Dr. Thomas Davis, Honors Thesis Advisor, Division of Health Promotion and Education, School of Health, Physical Education and Leisure Services __________ ______________________________________________________ Date Dr. -
SCIENCE and HEALTH MISINFORMATION in the DIGITAL AGE: How Does It Spread? Who Is Vulnerable? How Do We Fight It?
SCIENCE AND HEALTH MISINFORMATION IN THE DIGITAL AGE: How does it spread? Who is vulnerable? How do we fight it? ERIC MERKLEY & PETER LOEWEN J U LY, 2021 ABOUT PPF Good Policy. Better Canada. The Public Policy Forum builds bridges among diverse participants in the policy-making process and gives them a platform to examine issues, offer new perspectives and feed fresh ideas into critical policy discussions. We believe good policy is critical to making a better Canada—a country that’s cohesive, prosperous and secure. We contribute by: . Conducting research on critical issues . Convening candid dialogues on research subjects . Recognizing exceptional leaders Our approach—called Inclusion to Conclusion—brings emerging and established voices to policy conversations, which informs conclusions that identify obstacles to success and pathways forward. PPF is an independent, non-partisan charity whose members are a diverse group of private, public and non-profit organizations. ppforum.ca @ppforumca © 2021, Public Policy Forum 1400 - 130 Albert Street Ottawa, ON, Canada, K1P 5G4 613.238.7858 ISBN: 978-1-77452-085-7 WITH THANKS TO OUR PARTNERS ABOUT THE AUTHORS ERIC MERKLEY Eric Merkley (PhD, UBC) is an Assistant Professor in the Department of Political Science at the University of Toronto. He was the lead survey analyst of the Media Ecosystem Observatory, which studied the Canadian information ecosystem and public opinion during the COVID-19 pandemic, and the Digital Democracy Project, which studied misinformation and public attitudes during the 2019 Canadian federal election. His research focuses on the link between political elite behaviour, the news media, and public opinion. -
Interview of Dr. Boyd E. Haley by Teri Small
B.E. Haley and T. Small/Medical Veritas 3 (2006) 921–934 921 Interview with Dr. Boyd E. Haley: Biomarkers supporting mercury toxicity as the major exacerbator of neurological illness, recent evidence via the urinary porphyrin tests Boyd E. Haleya, PhD and Teri Smallb aProfessor and Chair bAutismOne Radio Department of Chemistry 1816 Houston Ave. University of Kentucky Fullerton, CA 92833 USA Email: [email protected] Email: [email protected] Website: www.autismone.org Abstract In the recent past, several biological finds have supported the hypothesis that early exposure of infants to Thimerosal was the major exacerbation factor in the increase in autism-related disorders since the advent of the mandated vaccine program. These initially included the observations of a genetic susceptibility impairing the excretion of mercury and the increased retention of mercury by autistic children. This was followed by data indi- cating that autistics have low levels of the natural compound glutathione that is necessary for the bilary excretion of mercury, possibly explaining the genetic susceptibility. Other observations clearly point out that various biochemical processes are inhibited at exceptionally low nanomolar levels of Thimerosal, including the killing of neurons in culture, the inhibition of the enzyme that makes methyl-B12, the inhibition of phagocytosis (the first step in the innate and acquired immune system), the inhibition of nerve growth factor function at levels not cytotoxic, and the negative effect on brain dendritic cells. It is also now quite clear from primate studies that Thimerosal, or more correctly, the ethylmercury from Thimerosal delivers mercury to the brain, and causes brain inorganic mercury levels higher than equal levels of methylmercury. -
IN the UNITED STATES COURT of FEDERAL CLAIMS OFFICE of SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 to Be Published
IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS No. 01-162V Filed: February 12, 2009 To Be Published * * * * * * * * * * * * * * * * * * * * * * * * * * * * COLTEN SNYDER, by and through * KATHRYN SNYDER and JOSEPH SNYDER, * his natural guardians and next friends * Omnibus Autism * Proceeding; * Autism Spectrum Disorder, * Pervasive Developmental * Disorder, Causation, Petitioners, * Measles, MMR, Mercury, * Thimerosal, Waiver v. * Applying Daubert, * Weight of Expert Opinions, SECRETARY OF THE DEPARTMENT * Credibility of Witnesses OF HEALTH AND HUMAN SERVICES, * * Respondent. * * * * * * * * * * * * * * * * * * * * * * * * * * * * * * Christopher W. Wickersham, Sr., Esq., Lloyd Bowers, Esq., and Thomas B. Powers, Esq., for petitioners. Alexis S. Babcock, Esq., Katherine Esposito, Esq., Voris Johnson, Esq., and Vincent Matanoski, Esq., U.S. Department of Justice, Washington, DC, for respondent. DECISION1 Vowell, Special Master: On March 22, 2001, Kathryn and Joseph Snyder [“petitioners”] filed a petition for compensation under the National Vaccine Injury Compensation Program, 42 U.S.C. 1 Vaccine Rule 18(b) provides the parties 14 days to request redaction of any material “(i) which is trade secret or commercial or financial information which is privileged and confidential, or (ii) which are medical files and similar files, the disclosure of which would constitute a clearly unwarranted invasion of privacy.” 42 U.S.C. § 300aa12(d)(4)(B). Petitioners have waived their right to request such redaction. See Petitioners’ Notice to W aive the 14-Day “W aiting” Period as Defined in Vaccine Rule 18(b), filed December 2, 2008. Respondent also waived the right to object to the disclosure of information submitted by respondent. See Respondent’s Consent to Disclosure, filed January 14, 2009. Accordingly, this decision will be publicly available immediately after it is filed. -
C:\Documents and Settings\Williams\Local Settings\Temp
Case 1:03-vv-00584-MBH Document 119 Filed 10/23/08 Page 1 of 239 UNITED STATES COURT OF FEDERAL CLAIMS IN RE: CLAIMS FOR VACCINE ) INJURIES RESULTING IN ) AUTISM SPECTRUM DISORDER, ) OR A SIMILAR ) NEURODEVELOPMENTAL ) DISORDER ) ----------------------------- ) FRED AND MYLINDA KING, ) PARENTS OF JORDAN KING, ) A MINOR, ) Petitioners, ) v. ) Docket No.: 03-584V SECRETARY OF HEALTH AND ) HUMAN SERVICES, ) Respondent. ) ----------------------------- ) GEORGE AND VICTORIA MEAD, ) PARENTS OF WILLIAM P. MEAD, ) A MINOR, ) Petitioners, ) v. ) Docket No. 03-215V SECRETARY OF HEALTH AND ) HUMAN SERVICES, ) Respondent. ) REVISED AND CORRECTED COPY Pages: 1456 through 1693/1775 Place: Washington, D.C. Date: May 16, 2008 HERITAGE REPORTING CORPORATION Official Reporters 1220 L Street, N.W., Suite 600 Washington, D.C. 20005-4018 (202) 628-4888 [email protected] Case 1:03-vv-00584-MBH Document 119 Filed 10/23/08 Page 2 of 239 1456 IN THE UNITED STATES COURT OF FEDERAL CLAIMS OFFICE OF SPECIAL MASTERS IN RE: CLAIMS FOR VACCINE ) INJURIES RESULTING IN ) AUTISM SPECTRUM DISORDER, ) OR A SIMILAR ) NEURODEVELOPMENTAL ) DISORDER ) ----------------------------- ) FRED AND MYLINDA KING, ) PARENTS OF JORDAN KING, ) A MINOR, ) ) Petitioners, ) ) v. ) Docket No.: 03-584V ) SECRETARY OF HEALTH AND ) HUMAN SERVICES, ) ) Respondent. ) ----------------------------- ) GEORGE AND VICTORIA MEAD, ) PARENTS OF WILLIAM P. MEAD, ) A MINOR, ) Petitioners, ) ) v. ) Docket No. 03-215V ) SECRETARY OF HEALTH AND ) HUMAN SERVICES, ) ) Respondent. ) Courtroom 402 National Courts Building 717 Madison Place NW Washington, D.C. Friday, May 16, 2008 The parties met, pursuant to adjournment, at 9:05 a.m. Heritage Reporting Corporation (202) 628-4888 Case 1:03-vv-00584-MBH Document 119 Filed 10/23/08 Page 3 of 239 1457 BEFORE: HONORABLE GEORGE L. -
Correlation of Influenza Vaccination and Influenza Incidence on Covid-19 Severity
Influenza and Covid-19 severity 1 Report Correlation of Influenza Vaccination and Influenza Incidence on Covid-19 Severity Mark Christopher Arokiaraj, MD DM, Cardiology, Pondicherry Institute of Medical Sciences, India 605014. [email protected] Key words: Covid-19, Influenza vaccination, Influenza lower respiratory tract infections, Mortality, Morbidity, Immunity. Abstract The pandemic of Covid-19 is evolving worldwide, and it is associated with high mortality and morbidity. There is a growing need to discuss the elements of coordinated strategy to control the spread and mitigate the severity and mortality of Covid-19. H1N1 vaccine and streptococcus pneumonia vaccines are available. The current analysis was performed to correlate the severity of Covid-19 and influenza (H1N1) vaccination statistics and also the influenza lower respiratory tract incidence. There is a correlation between Covid-19 related mortality and morbidity and the status of influenza vaccination, which appears protective. The tendency of correlation is more visualized as the pandemic is evolving. The case incidence and recovery parameters also showed a beneficial trend. Since evolutionarily influenza is close to SARS-CoV-2 viruses and shares some common epitopes and mechanisms, there is a possibility of partial protection to reduce the Covid-19 related severity using the influenza vaccination. In countries where influenza immunization is less, there is a correlation between lower respiratory tract infections (LRI) and influenza attributable to lower respiratory tract infections incidence and Covid-19 severity, which is beneficial. Receiver operating curve (ROC) statistics showed an area under the curve of 0.86 (CI 0.78 to 0.944, P <0.0001) to predict Covid-19 mortality >150/million, and a decreasing trend of influenza LRI episodes. -
Applied Behaviour Analysis & the Treatment of Autism
Applied Behaviour Analysis & the Treatment of Autism 1 Autism: Incidence Rates Happe (1998) suggested the figure common to most studies was between 4-10 per 10,000 births A number of authors have reported substantive and continuous increases in incidence rates Magnusson and Saemundsen (1996) reported that in Iceland (where all cases of autism are reported to the one institution, thereby maintaining minimal variations in diagnostic practices) the incidence rate has doubled over the last 20 years 2 Autism: An Epidemic? Rimland (1995) raised the possibility of an 'autism epidemic' Year % <3 yrs No. Children 65-'69 1 919 70-'79 5 4,184 80-'89 5 4,018 90-'93 8 6,785 94-'95 17 3,916 3 California Epidemic Increases Rick Rollens of the Mind Institute: August 2002 The California Department of Developmental Services recently reported another all time record number of children entering California's developmental services system who have received a professional diagnosis of DSM IV autism, not including PDD, NOS,Asperger's, or any other autism spectrum disorder such as rare genetic diseases like Fragile X 4 California Epidemic Increases A quarterly report for April-July 2002 showed that California added 846 children with level one DSM IV autism to its system This represents an all time record number of new cases for a quarterly report in the 31 year history of the system The report represents an 18% increase in new cases over the same quarter in the previous year and established autism as the number one disability This accounted for 40% of all intakes -
A Glimpse Into the Scary World of Vaccine Adjuvants
A Glimpse into the Scary World of Vaccine Adjuvants By Edda West – Published in VRAN Newsletter – Winter 2005 Adjuvants are formulated compounds, which when combined with vaccine antigens intensify the body's immune response. They are used to elicit an early, high and long- lasting immune response. "The chemical nature of adjuvants, their mode of action and their reactions, (side effect), are highly variable in terms of how they affect the immune system and how serious their adverse effects are due to the resultant hyper-activation of the immune system. While adjuvants enable the use of less antigen to achieve the desired immune response and reduce vaccine production costs, with few exceptions, adjuvants are foreign to the body and cause adverse reactions", writes Australian scientist Viera Scheibner Ph.D. (1) The most common adjuvant for human use is an aluminum salt called alum derived from aluminum hydroxide, or aluminum phosphate. A quick read of the scientific literature reveals that the neurotoxic effects of aluminum were recognized 100 years ago. Aluminum is a neurotoxicant and has been linked to Alzheimer's disease and other neurological disorders. Prior to 1980, kidney patients undergoing long term dialysis treatments often suffered dialysis encephalopathy syndrome, the result of acute intoxication by the use of an aluminum-containing dialysate. This is now avoided using modern techniques of water purification. In preterm infants, prolonged intravenous feeding with solutions containing aluminum is associated with impaired neurologic development. Scientists speculate that aluminum neurotoxicity may be related to cell damage via free radical production, impairment of glucose metabolism, and effects on nerve signal transduction. -
Lead Poisoning
LEAD POISONING www.drhyman.com 6 Tips to Help You Get the Lead Out Luckily there are steps you can take to help you heal from lead poisoning if you have been exposed. Try the following: 1. Find out if you are lead-toxic. The easiest test is a simple blood lead test. Be sure the lab can measure VERY low levels of lead accurately. Anything higher than 2 micrograms/deciliter is toxic and should be treated. Unfortunately, the blood test only checks for current or ongoing exposures, so you must also take a heavy metal challenge test with DMSA, EDTA, or DMPS, which can be administered by a doctor trained in heavy metal detoxification. (See www.functionalmedicine.org or www.acam.org to find a qualified doctor.) Consider undergoing chelation therapy if your lead levels are high. 2. Reduce your exposures by having a “no shoes in the house” policy. A great deal of lead can be tracked into your house in the dust on the soles of shoes. Leaving your shoes at the door helps reduce the amount of contamination in your home. 3. Test your water for heavy metals. There are a number of home test kits available online. If you prefer to have a professional test your water, call your city water provider or look for labs in your area that will perform this kind of test. 4. Buy a carbon or reverse osmosis water filter for your drinking water. These filters remove lead and other toxic substances like PCBs. They are my favorite kind of filter and the type I use in my home.